Rosa M. Yanez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.
Journal: Frontiers in immunology
Published: January 16, 2026
Improved efficacy and long-term protective effects of CXCR4/IL10 bioengineered mesenchymal stromal cells in a model of inflammatory bowel disease.
Journal: Bioengineering & translational medicine
Published: May 07, 2025
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances.
Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2024
Improving the therapeutic profile of MSCs: Cytokine priming reduces donor-dependent heterogeneity and enhances their immunomodulatory capacity.
Journal: Frontiers in immunology
Published: July 31, 2024
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.
Journal: Lancet (London, England)
Published: March 12, 2024
Corrigendum: MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.
Journal: Frontiers in immunology
Published: November 28, 2023
Study of the Effect of Wild-Type and Transiently Expressing CXCR4 and IL-10 Mesenchymal Stromal Cells in a Mouse Model of Peritonitis.
Journal: International journal of molecular sciences
Published: November 21, 2023
MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.
Journal: Frontiers in immunology
Published: March 24, 2023
Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model.
Journal: Frontiers in immunology
Published: October 05, 2022
Enforced mesenchymal stem cell tissue colonization counteracts immunopathology.
Journal: NPJ Regenerative medicine
Published: May 04, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I.
Journal: Molecular therapy. Methods & clinical development
Published: December 16, 2021
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Journal: Trials
Published: March 11, 2021
Last Updated: 09/26/2026